Lupin receives EIR from USFDA for Pithampur Unit-1 Facility with VAI Classification
The EIR was issued with an inspection classification of Voluntary Action Indicated (VAI) post the inspection of the facility from September 16 to September 27, 2024
The EIR was issued with an inspection classification of Voluntary Action Indicated (VAI) post the inspection of the facility from September 16 to September 27, 2024
The biosimilar Ustekinumab has been developed and manufactured by the company
Nadda chairs Joint Strategy Meeting with Line Ministries for TB Mukt Bharat Abhiyan- 100-Day Intensified Campaign
These three NDAs of Sitagliptin (base) and combination franchise have been approved by the USFDA earlier through the 505(b)(2) route
ICMR will continue to track trends in HMPV circulation throughout the year
He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables
2.92 acre facility will combine tradition and innovation, offering new opportunities for holistic healing, specialized clinics, and skill development to be constructed at a cost of around Rs. 185 crore
There was no casualty or loss of human life in the incidence
Brings together industry experts to discuss preventive steps to protect pigs from African swine fever and best practises for pig farm management
Parkinson's disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain
Subscribe To Our Newsletter & Stay Updated